CL2014000104A1 - Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico - Google Patents

Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico

Info

Publication number
CL2014000104A1
CL2014000104A1 CL2014000104A CL2014000104A CL2014000104A1 CL 2014000104 A1 CL2014000104 A1 CL 2014000104A1 CL 2014000104 A CL2014000104 A CL 2014000104A CL 2014000104 A CL2014000104 A CL 2014000104A CL 2014000104 A1 CL2014000104 A1 CL 2014000104A1
Authority
CL
Chile
Prior art keywords
photosensitive material
pharmaceutical product
exposure
analysis
inner chamber
Prior art date
Application number
CL2014000104A
Other languages
English (en)
Spanish (es)
Inventor
Jeremy Guo
Deborah Shnek
Paula Spencer
Li Sun
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2014000104A1 publication Critical patent/CL2014000104A1/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • B65D79/02—Arrangements or devices for indicating incorrect storage or transport
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
CL2014000104A 2011-09-02 2014-01-14 Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico CL2014000104A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161530824P 2011-09-02 2011-09-02

Publications (1)

Publication Number Publication Date
CL2014000104A1 true CL2014000104A1 (es) 2014-07-25

Family

ID=46982918

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000104A CL2014000104A1 (es) 2011-09-02 2014-01-14 Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico

Country Status (13)

Country Link
US (1) US20140315187A1 (fr)
EP (1) EP2750989A1 (fr)
JP (1) JP2014529473A (fr)
KR (1) KR20140058669A (fr)
CN (1) CN103917458A (fr)
AU (1) AU2012301656A1 (fr)
BR (1) BR112014004591A2 (fr)
CA (1) CA2840637A1 (fr)
CL (1) CL2014000104A1 (fr)
EA (1) EA201490555A1 (fr)
MX (1) MX2014002533A (fr)
WO (1) WO2013033600A1 (fr)
ZA (1) ZA201309704B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202785A1 (fr) 2015-06-17 2016-12-22 Novozymes A/S Contenant
IL250601B (en) * 2017-02-14 2018-05-31 Marpaz Tech Ltd Container for light sensitive material
CN113454438A (zh) * 2019-02-22 2021-09-28 科慕埃弗西有限公司 用于确定材料的感光特性的方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
EP0117390B1 (fr) * 1983-02-25 1990-09-05 Lifelines Technology, Inc. Procédé de surveillance de l'exposé incrémental à l'environnement des produits, subissant des changements de qualité progressifs suite aux stimulations extérieures
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DK0417563T3 (da) 1989-09-12 2000-11-06 Hoffmann La Roche TNF-bindende proteiner
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5962406A (en) 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
JPH06174600A (ja) * 1992-09-16 1994-06-24 Caterpillar Inc 状態変化を表示する方法および装置
ES2198414T3 (es) 1992-10-23 2004-02-01 Immunex Corporation Procedimientos para preparar proteinas oligomericas solubles.
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
DE69635480T2 (de) 1995-06-29 2006-08-17 Immunex Corp., Thousand Oaks Apoptosis induzierendes cytokin
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001036637A1 (fr) 1999-11-17 2001-05-25 Immunex Corporation Activateur du recepteur de nf-kappa b
CA2407956A1 (fr) 2000-05-03 2001-11-08 Amgen Inc. Peptides modifies utilises comme agents therapeutiques

Also Published As

Publication number Publication date
EP2750989A1 (fr) 2014-07-09
ZA201309704B (en) 2014-08-27
BR112014004591A2 (pt) 2017-03-28
MX2014002533A (es) 2014-08-26
WO2013033600A1 (fr) 2013-03-07
CN103917458A (zh) 2014-07-09
AU2012301656A1 (en) 2014-01-16
CA2840637A1 (fr) 2013-03-07
KR20140058669A (ko) 2014-05-14
US20140315187A1 (en) 2014-10-23
JP2014529473A (ja) 2014-11-13
EA201490555A1 (ru) 2014-07-30

Similar Documents

Publication Publication Date Title
EP3397398A4 (fr) Couche de biointerface pour détecteurs d'analyte
BRPI1006887A2 (pt) revestimento exterior reutilizável para um artigo absorvente
CL2015001511A1 (es) Proceso para producir un material de empaque revestido y material de empaque que tiene al menos una capa de barrera para compuestos hidrofóbicos.
EP3115430A4 (fr) Adhésif de lamination, film de lamination ainsi que procédé de fabrication de celui-ci, et matériau pour sachet stérilisable
CL2014002795A1 (es) Una formulacion de farmaco de liberacion retardada oral para suministrar un farmaco al colon que comprende un nucleo y un recubrimiento para el nucleo, el nucleo comprende un farmaco y el recubrimiento comprende una capa exterior con una mezcla de un primer y segundo material polimerico y una capa interior con un tercer material polimerico; y su metodo de preparacion.
BRPI0919044A2 (pt) conjunto de recipientes de dose de pó seco, inalador de pó seco, e, método para fabricar um conjunto de recipientes de dose
EP2696851A4 (fr) Dispositif d'administration d'un médicament constitué de plusieurs pellicules minces, et procédés de fabrication et d'utilisation associés
CO6821959A2 (es) Formas de dosificación farmacéutica intranasales que comprenden naloxona
BR112013020362A2 (pt) processos para a preparação de compostos de quinolina, compostos e combinações farmacêuticas que os contem
HK1219424A1 (zh) 含有他達拉非的口腔崩解型膜製劑及其製備方法
DK2582520T3 (da) UV-stråling-permeabel flerlagsfolie
BR112013018941A2 (pt) formas sólidas de dosagem revestidas com filme que compreende mel no revestimento.
DK2775986T3 (da) Filmemballage til orale biologiske stoffer
CL2014001016A1 (es) Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral.
IL215964A0 (en) Arc evaporation source and method for manufacturing film using same
CL2013003756A1 (es) Aparato de fabricacion de prenda de lamina para la fabricacion de una prenda de lamina para un articulo absorbente que comprende una pieza de cilindro que tiene una superficie externa que es generalmente cilindrica alrededor de un eje de rotacion a lo largo de uan direccion horizontal.
EP3368010A4 (fr) Forme galénique solide à libération immédiate de médicament et appareil et procédé de fabrication associés
EP3200877A4 (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
CL2014000104A1 (es) Producto farmaceutico que comprende un recipiente de superficie exterior y camara interior, una capa de material fotosensible en superficie exterior; metodo para confirmar correcta manipulacion de material fotosensible; y metodo de analisis de exposicion a la luz de un producto farmaceutico
IT201600078604A1 (it) Gruppo di trasporto per confezioni di contenitori ad uso farmaceutico
BR112014000217A2 (pt) formulação e método para a criação de uma formulação que estabiliza a proteína terapêutica
CL2008000609A1 (es) Metodo para sanear productos de animales que comprende la aplicacion de fagos a una capa externa de un cuerpo de un animal.
DK2387349T3 (da) Fremgangsmåde til inspektion af indersiden af en snæver slange eller et snævert rør, især til medicinsk brug
EP3411024A4 (fr) Forme pharmaceutique orale de film de loxapine
CL2013001626A1 (es) Composicion farmaceutica para la prevención y el tratamiento de una cardiovasculopatia que comprende clorhidrato de lercanidipina y valsartan; metodo para la preparacion de la misma.